More recently, we have shown that the S1PR1 inhibitor siponimod, when used as a single agent, can reduce angiogenesis and tumor growth in an animal model of angiogenic DLBCL [44]. The gene discussed is S1PR1; the disease is diffuse large B-cell lymphoma.